Related Experiment Video
Updated: Jul 3, 2026

Development of Cell-type specific anti-HIV gp120 aptamers for siRNA delivery
Published on: June 23, 2011
WITHDRAWN: Very strong synergy between modified RANTES and gp41 binding peptides leads to potent anti-HIV-1 activity
Hongjun Jin1, Edward B Siwak, Roger Smith
1Texas A&M University, Department of Biochemistry & Biophysics, College Station, Texas 77843-2128, U.S.A.; Department of Molecular Virology and Microbiology, Baylor College of Medicine, Houston, Texas 77030-3411 U.S.A.; Department of Veterinary Pathobiology, Texas A&M University, College Station, Texas 77843-4467, U.S.A.
Abstract:
This article, published ahead of print on 28 July 2008, has been withdrawn by the authors. Although moderate synergy between P2-RANTES and C peptides can be observed with high statistical significance in cell fusion assays, this synergy was not able to be verified in HIV viral assays. The authors regret the overstatement of synergy and will revise the paper for publication at a later date.
More Related Videos
07:10Conformational Evaluation of HIV-1 Trimeric Envelope Glycoproteins Using a Cell-based ELISA Assay
Published on: September 14, 2014
10:50Assessment of Immunologically Relevant Dynamic Tertiary Structural Features of the HIV-1 V3 Loop Crown R2 Sequence by ab initio Folding
Published on: September 15, 2010
Related Concept Videos
Inhibitors of Virion Maturation and Assembly
Retrovirus Life Cycles